Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL.
Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.
Dr. Reddy's unveiled its difluprednate ophthalmic emulsion in the US market for treating inflammation and pain associated with eye surgery.
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for.
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
The Covid-19 virus had claimed the lives of 170,000 people over the last eight weeks, after China lifted restrictions imposed during early stages.
The WHO has updated its list of medicines to stockpile for radiological and nuclear emergencies.
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for.
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com